JPRN-UMIN000050067招募中2 期
A Phase II study of the efficacy and safety of Perflubutane for predicting highly Tumor Infiltrating Lymphocytes in early breast cancer (AppTIL study) - A Phase II study of the Perflubutane for predicting TILs in EBC (AppTIL study)
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients undergoing preoperative treatment for breast cancer 2. Patients with a history of breast cancer on the affected side 3. Patients with a history of hypersensitivity to perflubutane 4. Patients with allergy to eggs or egg products 5. Patients with arteriovenous shunts in the heart or lungs 6. Patients with serious cardiac or pulmonary disease 7. Patients deemed inappropriate by the principal investigator or subinvestigator
研究者
相似试验
招募中
2 期
A Phase II study of the Perflubutane for predicting TILs in EBC (AppTIL study)Early Breast Cancer (cStage I-IIIA)Breast Cancer, TIL, Tumor Infiltrating Lymphocyte, LPBC, Contrast-enhanced ultrasonography, US, Perflubutane, SonazoidJPRN-jRCT1061220081Shigematsu Hideo100
已完成
不适用
Phase II study evaluating efficacy and safety of peripheral blood stem cell harvest with bortezomib for multiple myelomaMultiple MyelomaJPRN-UMIN000010258Fourth Department of Internal Medicine, Sapporo Medical University, School of Medicine30
已完成
不适用
Clinical trial for effectiveness and safety of percutaneous transhepatic gallbladder aspiration in patients with acute cholecystitisAcute cholecystitisJPRN-UMIN000002052Chiba University Graduate School of Medicine78
招募中
1 期
Clinical and translational controlled study of Perampanel treatment around Surgery in patients with progressive glioblastoma (PerSurge)Progressive GlioblastomaMedDRA version: 20.0Level: PTClassification code: 10018336Term: Glioblastoma Class: 100000004864CTIS2023-503938-52-00niversitaetsklinikum Heidelberg AöR66
已完成
2 期
Phase II analysis for efficacy and safety of perioperative pirfenidone (Pirespa) therapy for patients with non-small cell lung cancer combined with idiopathic pulmonary fibrosis (IPF)non-small-cell lung cancer combined with idiopathic pulmonary fibrosisJPRN-UMIN000007774West Japan Oncology Group42